Table 3.

3D Gamma analysis results for all patients (n = 40), prostate cohort (n = 20) and greater pelvis cohort (n = 20) for plans on sCT with Siemens Healthineers’ RED_sCT applied.

	3%/2 mm		2%/2 mm		1%/1 mm
	Pass Rate (%)	Av Gamma	Pass Rate (%)	Av Gamma	Pass Rate (%)	Av Gamma
All Patients	99.6 $\pm$ 1.0	0.18 $\pm$ 0.07	98.5 $\pm$ 2.6	0.27 $\pm$ 0.09	84.0 $\pm$ 9.7	0.53 $\pm$ 0.17
range	100.0–96.1	0.03–0.38	100.0–86.8	0.05–0.54	100–52.0	0.10–1.07
Prostate	100.0 $\pm$ 0.1	0.15$\pm$ 0.04	99.7 $\pm$ 0.4	0.22 $\pm$ 0.06	88.6 $\pm$ 5.3	0.44 $\pm$ 0.11
range	100.0–99.7	0.03–0.21	100.0–98.3	0.05–0.30	100.0–79.6	0.10–0.59
Greater Pelvis	99.1 $\pm$ 1.4	0.22 $\pm$ 0.07	97.3 $\pm$ 3.3	0.31 $\pm$ 0.09	79.5 $\pm$ 11.0	0.63 $\pm$ 0.18
Range	100.0–96.1	0.15–0.38	99.6–86.8	0.21–0.54	91.1–52.0	0.43–1.07